Investing Profile

Vikas Goyal

Photo of Vikas Goyal, Principal at SR One
Harvard University Network
254 CONNECTIONS
University of Pennsylvania Network
143 CONNECTIONS
McKinsey & Company Network
141 CONNECTIONS
The Wharton School Network
108 CONNECTIONS
cb
SR One Principal
8
CompanyStageDateRound SizeTotal Raised
Pandion Therapeutics
Series AJan 2018$58M
$140M
Co-investors: Alan Crane (Polaris Partners), Carlo Rizzuto (Versant Ventures), Dan Becker (Access Biotechnology)
Spero Therapeutics
Series CMar 2017$52M
Series BFeb 2016$30M
Series AJun 2015$30M
$120M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Michael Gladstone (Atlas Venture), Jean-François Formela (Atlas Venture), Reza Halse (RA Capital)
Morphic Therapeutic
Series AJun 2016$52M
$140M
Co-investors: Kevin Bitterman (Atlas Venture), Timothy A. Springer
CalciMedica
Series CDec 2009$12M
Series CJan 2009$4M
Series AJul 2007$2M
$18M
Associate SR One2011 - Present
Manager, Corporate Strategy & Development Infinity Pharmaceuticals2010 - 2011
Intern SR One2009 - 2010
Co-Chair TiE Social Entrepreneurs2006 - 2008
Senior Associate, Co-Founder Extera Partners2004 - 2008
Associate, PureTech Development PureTech Ventures2004 - 2007
Senior Analyst McKinsey & Company2001 - 2003
The Wharton School MBA Business
University of Pennsylvania MBA Health Care Management
Harvard University BA Neurobiology